Compare XLO & XOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XLO | XOS |
|---|---|---|
| Founded | 2016 | 2016 |
| Country | United States | United States |
| Employees | N/A | 101 |
| Industry | Biotechnology: Pharmaceutical Preparations | Construction/Ag Equipment/Trucks |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.9M | 41.4M |
| IPO Year | 2021 | 2020 |
| Metric | XLO | XOS |
|---|---|---|
| Price | $8.49 | $2.90 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 8.6K | ★ 155.3K |
| Earning Date | 11-12-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 59.49 |
| EPS | ★ N/A | N/A |
| Revenue | $43,766,000.00 | ★ $45,992,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $37.30 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 589.88 | N/A |
| 52 Week Low | $0.46 | $1.60 |
| 52 Week High | $25.17 | $8.27 |
| Indicator | XLO | XOS |
|---|---|---|
| Relative Strength Index (RSI) | 43.16 | 46.25 |
| Support Level | $8.52 | $1.90 |
| Resistance Level | $8.80 | $3.07 |
| Average True Range (ATR) | 0.33 | 0.27 |
| MACD | -0.03 | -0.03 |
| Stochastic Oscillator | 22.16 | 26.29 |
Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.
Xos Inc is a fleet electrification solutions provider committed to the decarbonization of commercial transportation. Xos designs and manufactures Class 5 through 8 battery-electric commercial vehicles that travel on last-mile, back-to-base routes of up to 200 miles per day. Xos also offers charging infrastructure products and services through Xos Energy Solutions to support electric vehicle fleets. Its products include Stepvan, MDXT, HDXT, Xosphere, and Xos Energy Solutions.